| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.32 | 1e-11 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.079 | 0.07 |